Flirtey and Vault Conduct Drone Deliveries of At-Home COVID-19 Test Kits
/PRNewswire/ — Flirtey, the pioneer of the commercial drone delivery industry, and Vault Health, the pioneer platform of supervised COVID-19 testing, today…
Related Articles
Healthcare Pioneers Medically Home Group and Siemens Healthineers Forge a Collaboration to Enhance Capabilities for Providing Advanced Patient Care at Home
/PRNewswire/ — Medically Home Group, the leading company in developing and operationalizing decentralized care to the home for patients with serious, complex,…
Women in U.S. Can Now Collect Their Own Sample for Cervical Cancer Screening
/PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration…
The Vitamin Shoppe® Launches Holistic Telehealth Service Featuring GLP-1 Medications, Including Ozempic®, Mounjaro®, and Low-Cost Semaglutide and Tirzepatide Options
/PRNewswire/ — The Vitamin Shoppe®, an omni-channel specialty retailer of nutritional products, today announced the launch of Whole Health Rx™ by The Vitamin…
Ro introduces the Ro Operating System (ro.OS)
/PRNewswire/ — Ro, the leading direct-to-patient healthcare company, today introduced the Ro Operating System (ro.OS) – its technology platform delivering…
NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients
/PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing novel treatments for severe neurodegenerative diseases,…
US FDA approves Boehringer Ingelheim’s high-concentration, citrate-free formulation of Cyltezo® (adalimumab-adbm) injection
/PRNewswire/ — Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the high-concentration, citrate-free…
MedStar Health Launches Participation in Phase 3 MAGNITUDE Gene-Editing Study with First U.S. Heart Patient Treated at MedStar Washington Hospital Center
Study examines if gene editing can help people living with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) WASHINGTON, May 2, 2024 /PRNewswire/ — The…
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
/PRNewswire/ — Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered…
IDTechEx Examines the Opportunities for Wearables in Digital Health
/PRNewswire/ — With every successive year, the lines between medical devices and consumer electronics become increasingly blurred – medtech companies seek to…
Invitae Enters into Agreement with Labcorp for Sale of Business
/PRNewswire/ — Invitae (OTC:NVTA), a leading medical genetics company, announced that Labcorp (NYSE: LH), a global leader of innovative and comprehensive…